slides · global inventory
Compare Peers
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,820
Current window 7,291-7,320
Pages 328
Rows per page 30
Slide function
7,291-7,320 of 9,820
15
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
33
Includes three dose-response curves and a comparative table of clinical stage and potency metrics.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
17
The slide highlights the unique 'Protein replacement' approach of Nomlabofusp compared to other modalities like Mitochondrial Oxidative Stress Modifiers, Gene Expression Regulators, Pathway Modifiers, and Gene Therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
08
Uses a checkmark/cross matrix to demonstrate competitive advantage.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a 2x2 matrix to illustrate a strategic pivot from a low-margin/low-multiple business model to a high-margin/high-multiple model.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo across efficacy, safety, and administration metrics.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
16
DCR stands for Disease Control Rate. The table compares historical benchmarks (Standard of Care) against the company's clinical trial results (THIO-101).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
25
The slide compares clinical trial data for three different treatment regimens in CRC patients.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The table compares historical standard of care data against planned THIO-102 trial outcomes.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
The table compares an existing standard of care (Zepzelca) against the company's planned trial (THIO-102).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
37
The slide uses a table-like layout to associate logos with market cap figures, followed by specific acquisition deal context.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pareto Focus1 hit
37
The chart highlights MAIN's efficiency by showing its operating expenses are lower than the peer group averages.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
04
Uses hub-and-spoke diagrams to visually represent decentralized vs centralized networks.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
19
The slide uses two scatter plots to compare diagnostic performance metrics against competitors like Guardant Health, CellMax Life, and Cologuard.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Market Size1 hit
07
The LNC column is highlighted in light yellow to emphasize the company's proprietary technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
10
Matson | Investor Presentation Deck | 14 slidesMatson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations 1 hit
15
The slide uses a bar chart to visualize effect sizes, with a supporting text box explaining the methodology and context.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
22
The chart shows Moelis significantly outperforming the benchmarks and peers with a 261% return.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
The chart uses red bars for negative growth and a blue bar for positive growth to emphasize the performance gap.Nano Dimension | Results Presentation Deck | 13 slides · Nano Dimension
Conference presentation Investor relations Beat · Future Potential1 hit
22
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · Visualization1 hit
12
The chart highlights the unique reach of Nextdoor compared to other social platforms.Nextdoor | Results Presentation Deck | 36 slides · Nextdoor
Conference presentation Investor relations 1 hit
13
The chart uses a multiplier (1.62x, etc.) to show relative reach compared to a baseline.Nextdoor | Results Presentation Deck | 36 slides · Nextdoor
Conference presentation Investor relations 1 hit
14
The chart highlights Nextdoor in green and other major platforms with their respective brand colors.Nextdoor | Results Presentation Deck | 36 slides · Nextdoor
Conference presentation Investor relations 1 hit
16
The chart uses a Marimekko-style visualization to show the relationship between user base size and monetization efficiency.Nextdoor | Results Presentation Deck | 36 slides · Nextdoor
Conference presentation Investor relations 1 hit
11
The table uses a green/white color coding to highlight positive attributes (Yes) versus negative ones (No).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
31
The table highlights NVL-655's superior profile in G1202R and GRLM/GRGA/GRLF activity compared to existing therapies.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
11
Peer data source: Federal Financial Institutions Examination Council database.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
14
Includes annotations regarding specific banks (SVB, BNY Mellon) and historical context on bank failures.PB Bankshares | Results Presentation Deck | 27 slides · PB Bankshares
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
21
The chart highlights IBM at the bottom of the top 10 list.SoftBank | Investor Presentation Deck | 103 slides · SoftBank
Pitch deck Investor relations Beat · HowLoop · Why Now1 hit